Genscript Biotech

Genscript Biotech Revenue per Share

The Revenue per Share of Genscript Biotech (1548.HK) as of Nov 6, 2026 is 0.43 USD. In the previous year, Revenue per Share was 0.03 USD — a change of 1,137.76% (higher).

Revenue per Share

0.43USD

YoY

1,137.76%

Last updated:

Revenue per Share of Genscript Biotech is 2025 0.43 USD. Revenue per Share of Genscript Biotech was 2024 0.03 USD. It decreases by 1,137.76% higher compared to the previous year.

The Genscript Biotech Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2024
0.03 USD
Jan 1, 2025
0.43 USD
Jan 1, 2026 (e)
0.41 USD
Jan 1, 2027 (e)
0.55 USD
Jan 1, 2028 (e)
0.69 USD
Jan 1, 2029 (e)
0.50 USD
Jan 1, 2030 (e)
0.55 USD
Jan 1, 2031 (e)
0.60 USD
The Genscript Biotech Revenue per Share history
YEARRevenue per ShareYoY
est0.60USD+9.11%
est0.55USD+9.52%
est0.50USD-27.48%
est0.69USD+26.17%
est0.55USD+32.30%
est0.41USD-4.24%
0.43USD+1,137.76%
0.03USD+2.83%
0.03USD-10.78%
0.04USD-84.52%
0.25USD+22.47%
0.20USD+37.50%
0.15USD+17.00%
0.12USD+40.67%
0.09USD+32.89%
0.07USD-4.87%
0.07USD+22.72%
0.06USD+51.73%
0.04USD+54.92%
0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

Revenue per Share of Genscript Biotech is 0.43 USD in 2025.

Revenue per Share of Genscript Biotech changed from 0.03 USD to 0.43 USD, representing a 1,137.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Genscript Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genscript Biotech